ArticleMolecular biotechnology2026
UCOE-Mediated Transcriptional Stabilization Combined with EGFP-Based FACS Screening Enables Efficient Selection of High-Producing CHO Cells.
Article in Molecular biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Position effects and transgene silencing remain major obstacles to the generation of stable high-producing CHO cell lines. Applying genetic regulatory elements, such as a ubiquitous chromatin-opening element (UCOE), can mitigate these limitations by maintaining a transcriptionally permissive chromatin environment and supporting sustained transgene expression. In parallel, EGFP-based fluorescence-activated cell sorting (FACS) enables a rapid and efficient platform for the identification and enrichment of high-producing cell populations. Here, we have used the combined strategy of FACS-based screening and UCOE to accelerate the clonal selection and enhance recombinant Darbepoetin alfa (DPO) productivity in Chinese Hamster Ovary (CHO) cells. Accordingly, two plasmids were designed: pOptiVEC™ (non-UCOE) and CET1019HD (containing a UCOE). Both contained a codon-optimized Darbepoetin alfa-LoxP-IRES-EGFP-LoxP-IRES-DHFR fragment. To achieve a stable cell line, the cassettes were linearized and transfected into CHO DG44 cells. Then, EGFP was used as a selection marker in FACS to enrich cells with the brightest green fluorescence intensity. Subsequently, DPO and EGFP expression were assessed at the transcriptional and protein levels using qRT-PCR, Flow cytometry, western blotting, and ELISA. Expression analysis revealed that all UCOE-containing cell pools exhibited higher DPO yield compared with non-UCOE populations. Indeed, FACS sorting and enrichment of UCOE-containing cells led to a clone with more than an eightfold increase in productivity. Moreover, isolating high-producing cells via FACS with a simple gate yielded a 1.5-fold increase in target protein concentration compared with unsorted cells. This study demonstrated that UCOE-mediated transcriptional stabilization establishes a robust expression framework while EGFP-based FACS screening enables efficient enrichment of high-producing cells. Combining them enhances protein yield with potential for further optimization in larger-scale applications.
Indexed as
Identifiers
42640421What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.